5 Interesting Learnings from Salesforce at $45 Billion ARR: 14% cRPO Growth, 6% Organic Growth, and $2.53 of EPS From Its Anthropic Stake
Salesforce reported Q2 FY27 with revenue of $11.345B (up 11%), cRPO up 14%, and non-GAAP EPS of $5.90 (up 103%). The company raised FY27 guidance to $46.1B-$46.4B. EPS growth was driven by gains on its Anthropic stake and a $25B buyback. Organic growth was 6.4%, excluding Informatica. AI-related revenue is ~$3.9B ARR, about 8% of total revenue. CEO Benioff declared the 'SaaSpocalypse' over.
How this was made
The 30-second read
Why it matters
Traders can use the cRPO acceleration and raised FY27 guidance as the core bull case, while monitoring leverage (debt-funded $25B buyback) and the operating-income flatness as key bear-case checks.
Market read
A bookings re-acceleration plus guidance lift can drive momentum, but the quality of earnings and the debt-funded capital structure are central to risk management.
What to watch
The article notes the current-versus-noncurrent RPO split matters and that noncurrent RPO growth lagged; if that mix does not improve, guidance durability could be questioned despite near-term cRPO strength.
Background
The piece discusses Salesforce’s Q2 FY27 results and interprets the bookings and AI monetization metrics, including how much of EPS strength comes from investment gains tied to Anthropic.
Ticker impact
Salesforce reported Q2 FY27 results with cRPO up 14%, FY27 guidance raised to $46.1B-$46.4B, and EPS boosted by Anthropic stake gains and a $25B buyback.
Near-term upside bias as the market reprices the order book (current vs noncurrent RPO split) and raised guidance, tempered by leverage and the non-operating nature of part of EPS.
It cites multiple fresh, decision-relevant datapoints tied to the quarter and outlook (cRPO trajectory, guidance range, buyback size, debt increase, and ex-investment EPS decline). However, the piece is an analysis writeup rather than the primary earnings release, so some details may be secondary framing.
Market effects
If Salesforce’s bookings re-acceleration is sustained, it can improve sentiment and read-through for large-cap B2B SaaS demand signals and AI monetization narratives.
Limited direct regional impact; the story is US-listed and sentiment-driven for global SaaS investors.
Global SaaS investors may treat the raised FY27 guidance and cRPO trajectory as a benchmark for AI-agent and data platform adoption.
Counterpoint
The EPS surge is heavily influenced by strategic investment markups (Anthropic stake) and buyback leverage, while operating income is essentially flat year-over-year, so the ‘SaaSpocalypse’ framing may overstate underlying demand strength.
Key entities
- companySalesforce
Q2 FY27 results with cRPO up 14%, FY27 guidance raised, and EPS boosted by Anthropic stake gains plus a $25B buyback.
- equity stakeAnthropic
Salesforce’s strategic investment whose mark-to-market gains are cited as a major driver of non-GAAP EPS.
- acquisitionInformatica
Its contract base and subscription revenue are described as embedded in cRPO and organic growth adjustments.
